サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1784900

成人幹細胞の世界市場

Adult Stem Cells

出版日
ページ情報
英文 204 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
成人幹細胞の世界市場
出版日: 2025年08月06日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 204 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

成人幹細胞の世界市場は2030年までに272億米ドルに達する見込み

2024年に147億米ドルと推定される成人幹細胞の世界市場は、2024年から2030年にかけてCAGR 10.9％で成長し、2030年には272億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである自家成人幹細胞は、CAGR 12.4％を記録し、分析期間終了までに183億米ドルに達すると予測されています。同種異系成人幹細胞セグメントの成長率は、分析期間中CAGR 8.1％と推定されます。

米国市場は39億米ドルと推定、中国はCAGR 9.8％で成長予測

米国の成人幹細胞市場は2024年に39億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに42億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは9.8%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ9.8%と8.7%と予測されています。欧州では、ドイツがCAGR約8.3%で成長すると予測されています。

世界の成人幹細胞市場- 主要動向と促進要因のまとめ

なぜ成人幹細胞がヘルスケアに革命を起こすのか？

成人幹細胞は再生医療の最前線にあり、損傷した組織や臓器を修復したり置き換えたりすることで、様々な病気を治療できる可能性を提供しています。胚性幹細胞とは異なり、成人幹細胞は骨髄、脂肪組織、血液などの完全に発達した組織から採取されるため、倫理的にも法的にも問題が少ないです。その自己複製能力と様々な細胞に分化する能力は、最先端の治療アプローチの要として位置づけられています。

成人幹細胞の臨床応用には、変形性関節症、心血管疾患、神経変性疾患などの治療が含まれます。さらに、これらの細胞は、個別化医療、組織工学、さらには美容整形への応用も検討されています。世界人口の高齢化と慢性疾患の蔓延に伴い、効果的で低侵襲な治療に対する需要は増加の一途をたどっており、現代ヘルスケアにおける成人幹細胞の役割は確固たるものとなっています。

技術の進歩は市場をどのように形成しているか？

技術革新は成体幹細胞研究とその応用を大きく前進させています。細胞の単離・拡大技術の進歩により、より質の高い幹細胞を大規模に生産できるようになり、臨床試験や治療薬製造のニーズに対応できるようになりました。バイオリアクターや自動化された細胞処理システムは、生産をさらに合理化し、コスト削減と再現性の向上を実現した。

CRISPR-Cas9のような遺伝子編集技術もまた、遺伝子の変異を修正したり、細胞が所望の形質を示すように操作したりすることで、成人幹細胞の治療可能性を高めています。さらに、凍結保存技術によって幹細胞の保存と輸送が改善され、長期間の生存が保証されています。これらの進歩は、幹細胞の応用範囲を広げると同時に、世界中の患者にとってより身近な治療法となっています。

各治療領域における成人幹細胞の需要の原動力は？

成人幹細胞の需要は、その汎用性と有効性を反映し、複数の治療分野にまたがっています。整形外科では、幹細胞は軟骨の修復や関節障害の治療に広く使用されており、侵襲的な手術に代わる治療法を提供しています。心血管系の治療では、幹細胞が損傷した心臓組織の再生に活用され、心不全やその関連疾患に対する画期的な治療法となっています。

パーキンソン病やアルツハイマー病のような神経変性疾患も、幹細胞によって病気の進行を遅らせたり、失われた機能を回復させたりすることが期待されています。さらに、骨髄移植を含む血液学的用途は、依然として市場の重要な分野です。アンチエイジング治療や皮膚再生といった美容・皮膚科学的用途もまた、美的ソリューションに対する需要の高まりに対応し、市場の成長に寄与しています。

成人幹細胞市場の成長を促進する要因とは？

成人幹細胞市場の成長は、いくつかの要因によって牽引されています。慢性疾患の増加と世界の高齢化により、高度な再生治療に対するニーズが高まっています。細胞の分離、拡大、遺伝子工学の技術的進歩により、幹細胞応用の治療可能性と拡張性が高まっています。

幹細胞の研究開発への投資の増加と、政府の政策や規制の枠組みが相まって、市場の成長はさらに加速しています。個別化医療や組織工学への応用が拡大していることも、需要に寄与しています。さらに、治療と美容の両面で低侵襲手術が受け入れられつつあることは、現代医療の基礎として成人幹細胞への依存が高まっていることを裏付けています。これらの要因から、成人幹細胞がヘルスケアの未来に変革的なインパクトを与えることがわかります。

セグメント

タイプ（自己由来成人幹細胞,同種成人幹細胞）、製品・サービス（成人幹細胞製品,成人幹細胞サービス）、用途（治療用途,疾患モデル用途,医薬品開発・発見用途,毒性研究用途,バイオバンク用途,組織工学用途,その他用途）、最終用途（バイオ製薬企業最終用途,研究機関最終用途,病院・クリニック最終用途）

調査対象企業の例

  • Celltex Therapeutics
  • CTI Biotech
  • Fate Therapeutics, Inc.
  • GlobalStemCellCare
  • Juvena Therapeutics, inc.
  • Mesoblast Ltd.
  • Stemcell Technologies Canada, Inc.
  • Stemedica Cell Technologies, Inc.
  • Stempeutics Research Pvt., Ltd.
  • Thermo Fisher Scientific, Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家からキュレートされたコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP28987

Global Adult Stem Cells Market to Reach US$27.2 Billion by 2030

The global market for Adult Stem Cells estimated at US$14.7 Billion in the year 2024, is expected to reach US$27.2 Billion by 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Autologous Adult Stem Cells, one of the segments analyzed in the report, is expected to record a 12.4% CAGR and reach US$18.3 Billion by the end of the analysis period. Growth in the Allogeneic Adult Stem Cells segment is estimated at 8.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.9 Billion While China is Forecast to Grow at 9.8% CAGR

The Adult Stem Cells market in the U.S. is estimated at US$3.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.2 Billion by the year 2030 trailing a CAGR of 9.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.8% and 8.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR.

Global Adult Stem Cells Market - Key Trends & Drivers Summarized

Why Are Adult Stem Cells Revolutionizing Healthcare?

Adult stem cells are at the forefront of regenerative medicine, offering the potential to treat a wide range of diseases by repairing or replacing damaged tissues and organs. Unlike embryonic stem cells, adult stem cells are sourced from fully developed tissues such as bone marrow, adipose tissue, and blood, making them ethically and legally less contentious. Their ability to self-renew and differentiate into various cell types positions them as a cornerstone of cutting-edge therapeutic approaches.

The clinical applications of adult stem cells include treatments for conditions such as osteoarthritis, cardiovascular diseases, and neurodegenerative disorders. Additionally, these cells are being explored for use in personalized medicine, tissue engineering, and even cosmetic procedures. As the global population ages and chronic diseases become more prevalent, the demand for effective, minimally invasive treatments continues to grow, solidifying the role of adult stem cells in modern healthcare.

How Are Advancements in Technology Shaping the Market?

Technological innovations are driving significant progress in adult stem cell research and applications. Advances in cell isolation and expansion techniques have enabled the production of higher-quality stem cells at scale, addressing the needs of clinical trials and therapeutic manufacturing. Bioreactors and automated cell processing systems have further streamlined production, reducing costs and improving reproducibility.

Gene-editing technologies like CRISPR-Cas9 are also enhancing the therapeutic potential of adult stem cells by correcting genetic mutations or engineering cells to exhibit desired traits. Additionally, cryopreservation techniques have improved the storage and transport of stem cells, ensuring their viability for extended periods. These advancements are expanding the scope of stem cell applications while making therapies more accessible to patients worldwide.

What Drives Demand for Adult Stem Cells Across Therapeutic Areas?

The demand for adult stem cells spans multiple therapeutic areas, reflecting their versatility and effectiveness. In orthopedics, stem cells are widely used to repair cartilage and treat joint disorders, offering an alternative to invasive surgeries. Cardiovascular treatments leverage stem cells for regenerating damaged heart tissues, a breakthrough in addressing heart failure and related conditions.

Neurodegenerative diseases such as Parkinson’s and Alzheimer’s are another major focus area, with stem cells providing hope for slowing disease progression or restoring lost functions. Additionally, hematological applications, including bone marrow transplants, remain a critical segment of the market. Cosmetic and dermatological uses, such as anti-aging treatments and skin regeneration, are also contributing to the market’s growth, catering to the rising demand for aesthetic solutions.

What Factors Are Driving Growth in the Adult Stem Cells Market?

The growth in the adult stem cells market is driven by several factors. Increasing prevalence of chronic diseases and the global aging population have created a significant need for advanced and regenerative treatments. Technological advancements in cell isolation, expansion, and genetic engineering have enhanced the therapeutic potential and scalability of stem cell applications.

Rising investment in stem cell research and development, coupled with supportive government policies and regulatory frameworks, has further accelerated market growth. Expanding applications in personalized medicine and tissue engineering are also contributing to demand. Moreover, the growing acceptance of minimally invasive procedures, both in therapeutic and cosmetic contexts, underscores the increasing reliance on adult stem cells as a cornerstone of modern medicine. These factors collectively highlight the transformative impact of adult stem cells on the future of healthcare.

SCOPE OF STUDY:

The report analyzes the Adult Stem Cells market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Autologous Adult Stem Cells, Allogeneic Adult Stem Cells); Products and Services (Adult Stem Cell Product, Adult Stem Cell Services); Application (Therapeutics Application, Disease Modeling Application, Drug Development and Discovery Application, Toxicology Studies Application, Biobanking Application, Tissue Engineering Application, Other Applications); End-Use (Biopharmaceutical Companies End-Use, Research Institutes End-Use, Hospitals and Clinics End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 36 Featured) -

  • Celltex Therapeutics
  • CTI Biotech
  • Fate Therapeutics, Inc.
  • GlobalStemCellCare
  • Juvena Therapeutics, inc.
  • Mesoblast Ltd.
  • Stemcell Technologies Canada, Inc.
  • Stemedica Cell Technologies, Inc.
  • Stempeutics Research Pvt., Ltd.
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Adult Stem Cells - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Regenerative Medicine and Personalized Therapies
    • Increasing Investments in Stem Cell Research and Clinical Trials
    • Rising Adoption of Stem Cell Therapies for Chronic Disease Treatment
    • Expanding Applications in Orthopedic, Cardiovascular, and Neurological Disorders
    • Advancements in Stem Cell Isolation, Expansion, and Storage Technologies
    • Growing Popularity of Autologous and Allogeneic Stem Cell Therapies
    • Increasing Collaboration Between Biotech Firms and Research Institutions
    • Expansion of Stem Cell Banking and Storage Services
    • Rising Use of Stem Cells in Anti-Aging and Cosmetic Applications
    • Technological Innovations in 3D Bioprinting and Tissue Engineering
    • Growing Awareness and Acceptance of Stem Cell-Based Therapies
    • Emerging Potential of Adult Stem Cells in Drug Discovery and Toxicology Studies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Adult Stem Cells Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Adult Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Adult Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Autologous Adult Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Autologous Adult Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Allogeneic Adult Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Allogeneic Adult Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Tissue Engineering Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Tissue Engineering Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Therapeutics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Therapeutics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Disease Modeling Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Disease Modeling Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Drug Development & Discovery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Drug Development & Discovery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Toxicology Studies Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Toxicology Studies Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Biobanking Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Biobanking Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Biopharmaceutical Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Biopharmaceutical Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Adult Stem Cell Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Adult Stem Cell Product by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Adult Stem Cell Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for Adult Stem Cell Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Adult Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Adult Stem Cells by Type - Autologous Adult Stem Cells and Allogeneic Adult Stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Adult Stem Cells by Type - Percentage Breakdown of Value Sales for Autologous Adult Stem Cells and Allogeneic Adult Stem Cells for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Adult Stem Cells by Application - Tissue Engineering Application, Other Applications, Therapeutics Application, Disease Modeling Application, Drug Development & Discovery Application, Toxicology Studies Application and Biobanking Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Adult Stem Cells by Application - Percentage Breakdown of Value Sales for Tissue Engineering Application, Other Applications, Therapeutics Application, Disease Modeling Application, Drug Development & Discovery Application, Toxicology Studies Application and Biobanking Application for the Years 2025 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Adult Stem Cells by End-Use - Biopharmaceutical Companies End-Use, Research Institutes End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for Adult Stem Cells by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Research Institutes End-Use and Hospitals & Clinics End-Use for the Years 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Adult Stem Cells by Products & Services - Adult Stem Cell Product and Adult Stem Cell Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for Adult Stem Cells by Products & Services - Percentage Breakdown of Value Sales for Adult Stem Cell Product and Adult Stem Cell Services for the Years 2025 & 2030
  • CANADA
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Adult Stem Cells by Type - Autologous Adult Stem Cells and Allogeneic Adult Stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Adult Stem Cells by Type - Percentage Breakdown of Value Sales for Autologous Adult Stem Cells and Allogeneic Adult Stem Cells for the Years 2025 & 2030
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Adult Stem Cells by Application - Tissue Engineering Application, Other Applications, Therapeutics Application, Disease Modeling Application, Drug Development & Discovery Application, Toxicology Studies Application and Biobanking Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Canada 6-Year Perspective for Adult Stem Cells by Application - Percentage Breakdown of Value Sales for Tissue Engineering Application, Other Applications, Therapeutics Application, Disease Modeling Application, Drug Development & Discovery Application, Toxicology Studies Application and Biobanking Application for the Years 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Adult Stem Cells by End-Use - Biopharmaceutical Companies End-Use, Research Institutes End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for Adult Stem Cells by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Research Institutes End-Use and Hospitals & Clinics End-Use for the Years 2025 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Adult Stem Cells by Products & Services - Adult Stem Cell Product and Adult Stem Cell Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for Adult Stem Cells by Products & Services - Percentage Breakdown of Value Sales for Adult Stem Cell Product and Adult Stem Cell Services for the Years 2025 & 2030
  • JAPAN
    • Adult Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 48: Japan Recent Past, Current & Future Analysis for Adult Stem Cells by Type - Autologous Adult Stem Cells and Allogeneic Adult Stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Japan 6-Year Perspective for Adult Stem Cells by Type - Percentage Breakdown of Value Sales for Autologous Adult Stem Cells and Allogeneic Adult Stem Cells for the Years 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Adult Stem Cells by Application - Tissue Engineering Application, Other Applications, Therapeutics Application, Disease Modeling Application, Drug Development & Discovery Application, Toxicology Studies Application and Biobanking Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan 6-Year Perspective for Adult Stem Cells by Application - Percentage Breakdown of Value Sales for Tissue Engineering Application, Other Applications, Therapeutics Application, Disease Modeling Application, Drug Development & Discovery Application, Toxicology Studies Application and Biobanking Application for the Years 2025 & 2030
    • TABLE 52: Japan Recent Past, Current & Future Analysis for Adult Stem Cells by End-Use - Biopharmaceutical Companies End-Use, Research Institutes End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Japan 6-Year Perspective for Adult Stem Cells by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Research Institutes End-Use and Hospitals & Clinics End-Use for the Years 2025 & 2030
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Adult Stem Cells by Products & Services - Adult Stem Cell Product and Adult Stem Cell Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for Adult Stem Cells by Products & Services - Percentage Breakdown of Value Sales for Adult Stem Cell Product and Adult Stem Cell Services for the Years 2025 & 2030
  • CHINA
    • Adult Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Adult Stem Cells by Type - Autologous Adult Stem Cells and Allogeneic Adult Stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China 6-Year Perspective for Adult Stem Cells by Type - Percentage Breakdown of Value Sales for Autologous Adult Stem Cells and Allogeneic Adult Stem Cells for the Years 2025 & 2030
    • TABLE 58: China Recent Past, Current & Future Analysis for Adult Stem Cells by Application - Tissue Engineering Application, Other Applications, Therapeutics Application, Disease Modeling Application, Drug Development & Discovery Application, Toxicology Studies Application and Biobanking Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: China 6-Year Perspective for Adult Stem Cells by Application - Percentage Breakdown of Value Sales for Tissue Engineering Application, Other Applications, Therapeutics Application, Disease Modeling Application, Drug Development & Discovery Application, Toxicology Studies Application and Biobanking Application for the Years 2025 & 2030
    • TABLE 60: China Recent Past, Current & Future Analysis for Adult Stem Cells by End-Use - Biopharmaceutical Companies End-Use, Research Institutes End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: China 6-Year Perspective for Adult Stem Cells by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Research Institutes End-Use and Hospitals & Clinics End-Use for the Years 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Adult Stem Cells by Products & Services - Adult Stem Cell Product and Adult Stem Cell Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China 6-Year Perspective for Adult Stem Cells by Products & Services - Percentage Breakdown of Value Sales for Adult Stem Cell Product and Adult Stem Cell Services for the Years 2025 & 2030
  • EUROPE
    • Adult Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Adult Stem Cells by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 65: Europe 6-Year Perspective for Adult Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Adult Stem Cells by Type - Autologous Adult Stem Cells and Allogeneic Adult Stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Europe 6-Year Perspective for Adult Stem Cells by Type - Percentage Breakdown of Value Sales for Autologous Adult Stem Cells and Allogeneic Adult Stem Cells for the Years 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Adult Stem Cells by Application - Tissue Engineering Application, Other Applications, Therapeutics Application, Disease Modeling Application, Drug Development & Discovery Application, Toxicology Studies Application and Biobanking Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Adult Stem Cells by Application - Percentage Breakdown of Value Sales for Tissue Engineering Application, Other Applications, Therapeutics Application, Disease Modeling Application, Drug Development & Discovery Application, Toxicology Studies Application and Biobanking Application for the Years 2025 & 2030
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Adult Stem Cells by End-Use - Biopharmaceutical Companies End-Use, Research Institutes End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Adult Stem Cells by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Research Institutes End-Use and Hospitals & Clinics End-Use for the Years 2025 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Adult Stem Cells by Products & Services - Adult Stem Cell Product and Adult Stem Cell Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Europe 6-Year Perspective for Adult Stem Cells by Products & Services - Percentage Breakdown of Value Sales for Adult Stem Cell Product and Adult Stem Cell Services for the Years 2025 & 2030
  • FRANCE
    • Adult Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Adult Stem Cells by Type - Autologous Adult Stem Cells and Allogeneic Adult Stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France 6-Year Perspective for Adult Stem Cells by Type - Percentage Breakdown of Value Sales for Autologous Adult Stem Cells and Allogeneic Adult Stem Cells for the Years 2025 & 2030
    • TABLE 76: France Recent Past, Current & Future Analysis for Adult Stem Cells by Application - Tissue Engineering Application, Other Applications, Therapeutics Application, Disease Modeling Application, Drug Development & Discovery Application, Toxicology Studies Application and Biobanking Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: France 6-Year Perspective for Adult Stem Cells by Application - Percentage Breakdown of Value Sales for Tissue Engineering Application, Other Applications, Therapeutics Application, Disease Modeling Application, Drug Development & Discovery Application, Toxicology Studies Application and Biobanking Application for the Years 2025 & 2030
    • TABLE 78: France Recent Past, Current & Future Analysis for Adult Stem Cells by End-Use - Biopharmaceutical Companies End-Use, Research Institutes End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: France 6-Year Perspective for Adult Stem Cells by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Research Institutes End-Use and Hospitals & Clinics End-Use for the Years 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Adult Stem Cells by Products & Services - Adult Stem Cell Product and Adult Stem Cell Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France 6-Year Perspective for Adult Stem Cells by Products & Services - Percentage Breakdown of Value Sales for Adult Stem Cell Product and Adult Stem Cell Services for the Years 2025 & 2030
  • GERMANY
    • Adult Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 82: Germany Recent Past, Current & Future Analysis for Adult Stem Cells by Type - Autologous Adult Stem Cells and Allogeneic Adult Stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Germany 6-Year Perspective for Adult Stem Cells by Type - Percentage Breakdown of Value Sales for Autologous Adult Stem Cells and Allogeneic Adult Stem Cells for the Years 2025 & 2030
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Adult Stem Cells by Application - Tissue Engineering Application, Other Applications, Therapeutics Application, Disease Modeling Application, Drug Development & Discovery Application, Toxicology Studies Application and Biobanking Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Germany 6-Year Perspective for Adult Stem Cells by Application - Percentage Breakdown of Value Sales for Tissue Engineering Application, Other Applications, Therapeutics Application, Disease Modeling Application, Drug Development & Discovery Application, Toxicology Studies Application and Biobanking Application for the Years 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Adult Stem Cells by End-Use - Biopharmaceutical Companies End-Use, Research Institutes End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany 6-Year Perspective for Adult Stem Cells by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Research Institutes End-Use and Hospitals & Clinics End-Use for the Years 2025 & 2030
    • TABLE 88: Germany Recent Past, Current & Future Analysis for Adult Stem Cells by Products & Services - Adult Stem Cell Product and Adult Stem Cell Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Germany 6-Year Perspective for Adult Stem Cells by Products & Services - Percentage Breakdown of Value Sales for Adult Stem Cell Product and Adult Stem Cell Services for the Years 2025 & 2030
  • ITALY
    • TABLE 90: Italy Recent Past, Current & Future Analysis for Adult Stem Cells by Type - Autologous Adult Stem Cells and Allogeneic Adult Stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Italy 6-Year Perspective for Adult Stem Cells by Type - Percentage Breakdown of Value Sales for Autologous Adult Stem Cells and Allogeneic Adult Stem Cells for the Years 2025 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Adult Stem Cells by Application - Tissue Engineering Application, Other Applications, Therapeutics Application, Disease Modeling Application, Drug Development & Discovery Application, Toxicology Studies Application and Biobanking Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy 6-Year Perspective for Adult Stem Cells by Application - Percentage Breakdown of Value Sales for Tissue Engineering Application, Other Applications, Therapeutics Application, Disease Modeling Application, Drug Development & Discovery Application, Toxicology Studies Application and Biobanking Application for the Years 2025 & 2030
    • TABLE 94: Italy Recent Past, Current & Future Analysis for Adult Stem Cells by End-Use - Biopharmaceutical Companies End-Use, Research Institutes End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Italy 6-Year Perspective for Adult Stem Cells by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Research Institutes End-Use and Hospitals & Clinics End-Use for the Years 2025 & 2030
    • TABLE 96: Italy Recent Past, Current & Future Analysis for Adult Stem Cells by Products & Services - Adult Stem Cell Product and Adult Stem Cell Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Italy 6-Year Perspective for Adult Stem Cells by Products & Services - Percentage Breakdown of Value Sales for Adult Stem Cell Product and Adult Stem Cell Services for the Years 2025 & 2030
  • UNITED KINGDOM
    • Adult Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 98: UK Recent Past, Current & Future Analysis for Adult Stem Cells by Type - Autologous Adult Stem Cells and Allogeneic Adult Stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK 6-Year Perspective for Adult Stem Cells by Type - Percentage Breakdown of Value Sales for Autologous Adult Stem Cells and Allogeneic Adult Stem Cells for the Years 2025 & 2030
    • TABLE 100: UK Recent Past, Current & Future Analysis for Adult Stem Cells by Application - Tissue Engineering Application, Other Applications, Therapeutics Application, Disease Modeling Application, Drug Development & Discovery Application, Toxicology Studies Application and Biobanking Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 101: UK 6-Year Perspective for Adult Stem Cells by Application - Percentage Breakdown of Value Sales for Tissue Engineering Application, Other Applications, Therapeutics Application, Disease Modeling Application, Drug Development & Discovery Application, Toxicology Studies Application and Biobanking Application for the Years 2025 & 2030
    • TABLE 102: UK Recent Past, Current & Future Analysis for Adult Stem Cells by End-Use - Biopharmaceutical Companies End-Use, Research Institutes End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 103: UK 6-Year Perspective for Adult Stem Cells by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Research Institutes End-Use and Hospitals & Clinics End-Use for the Years 2025 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Adult Stem Cells by Products & Services - Adult Stem Cell Product and Adult Stem Cell Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK 6-Year Perspective for Adult Stem Cells by Products & Services - Percentage Breakdown of Value Sales for Adult Stem Cell Product and Adult Stem Cell Services for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 106: Rest of Europe Recent Past, Current & Future Analysis for Adult Stem Cells by Type - Autologous Adult Stem Cells and Allogeneic Adult Stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Rest of Europe 6-Year Perspective for Adult Stem Cells by Type - Percentage Breakdown of Value Sales for Autologous Adult Stem Cells and Allogeneic Adult Stem Cells for the Years 2025 & 2030
    • TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Adult Stem Cells by Application - Tissue Engineering Application, Other Applications, Therapeutics Application, Disease Modeling Application, Drug Development & Discovery Application, Toxicology Studies Application and Biobanking Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Rest of Europe 6-Year Perspective for Adult Stem Cells by Application - Percentage Breakdown of Value Sales for Tissue Engineering Application, Other Applications, Therapeutics Application, Disease Modeling Application, Drug Development & Discovery Application, Toxicology Studies Application and Biobanking Application for the Years 2025 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Adult Stem Cells by End-Use - Biopharmaceutical Companies End-Use, Research Institutes End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe 6-Year Perspective for Adult Stem Cells by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Research Institutes End-Use and Hospitals & Clinics End-Use for the Years 2025 & 2030
    • TABLE 112: Rest of Europe Recent Past, Current & Future Analysis for Adult Stem Cells by Products & Services - Adult Stem Cell Product and Adult Stem Cell Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Rest of Europe 6-Year Perspective for Adult Stem Cells by Products & Services - Percentage Breakdown of Value Sales for Adult Stem Cell Product and Adult Stem Cell Services for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Adult Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 114: Asia-Pacific Recent Past, Current & Future Analysis for Adult Stem Cells by Type - Autologous Adult Stem Cells and Allogeneic Adult Stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Asia-Pacific 6-Year Perspective for Adult Stem Cells by Type - Percentage Breakdown of Value Sales for Autologous Adult Stem Cells and Allogeneic Adult Stem Cells for the Years 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Adult Stem Cells by Application - Tissue Engineering Application, Other Applications, Therapeutics Application, Disease Modeling Application, Drug Development & Discovery Application, Toxicology Studies Application and Biobanking Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific 6-Year Perspective for Adult Stem Cells by Application - Percentage Breakdown of Value Sales for Tissue Engineering Application, Other Applications, Therapeutics Application, Disease Modeling Application, Drug Development & Discovery Application, Toxicology Studies Application and Biobanking Application for the Years 2025 & 2030
    • TABLE 118: Asia-Pacific Recent Past, Current & Future Analysis for Adult Stem Cells by End-Use - Biopharmaceutical Companies End-Use, Research Institutes End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Asia-Pacific 6-Year Perspective for Adult Stem Cells by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Research Institutes End-Use and Hospitals & Clinics End-Use for the Years 2025 & 2030
    • TABLE 120: Asia-Pacific Recent Past, Current & Future Analysis for Adult Stem Cells by Products & Services - Adult Stem Cell Product and Adult Stem Cell Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Asia-Pacific 6-Year Perspective for Adult Stem Cells by Products & Services - Percentage Breakdown of Value Sales for Adult Stem Cell Product and Adult Stem Cell Services for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 122: Rest of World Recent Past, Current & Future Analysis for Adult Stem Cells by Type - Autologous Adult Stem Cells and Allogeneic Adult Stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of World 6-Year Perspective for Adult Stem Cells by Type - Percentage Breakdown of Value Sales for Autologous Adult Stem Cells and Allogeneic Adult Stem Cells for the Years 2025 & 2030
    • TABLE 124: Rest of World Recent Past, Current & Future Analysis for Adult Stem Cells by Application - Tissue Engineering Application, Other Applications, Therapeutics Application, Disease Modeling Application, Drug Development & Discovery Application, Toxicology Studies Application and Biobanking Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of World 6-Year Perspective for Adult Stem Cells by Application - Percentage Breakdown of Value Sales for Tissue Engineering Application, Other Applications, Therapeutics Application, Disease Modeling Application, Drug Development & Discovery Application, Toxicology Studies Application and Biobanking Application for the Years 2025 & 2030
    • TABLE 126: Rest of World Recent Past, Current & Future Analysis for Adult Stem Cells by End-Use - Biopharmaceutical Companies End-Use, Research Institutes End-Use and Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of World 6-Year Perspective for Adult Stem Cells by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Research Institutes End-Use and Hospitals & Clinics End-Use for the Years 2025 & 2030
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Adult Stem Cells by Products & Services - Adult Stem Cell Product and Adult Stem Cell Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of World 6-Year Perspective for Adult Stem Cells by Products & Services - Percentage Breakdown of Value Sales for Adult Stem Cell Product and Adult Stem Cell Services for the Years 2025 & 2030

IV. COMPETITION